Quarterly report pursuant to Section 13 or 15(d)

Joint Venture and Options Transaction (Details)

v3.20.4
Joint Venture and Options Transaction (Details) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 01, 2020
Dec. 23, 2019
Jun. 24, 2019
Feb. 04, 2019
Jan. 29, 2019
Oct. 31, 2018
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2020
Nov. 30, 2019
Joint Venture and Options Transaction (Details) [Line Items]                    
Financing Receivable, after Allowance for Credit Loss, Current           $ 5,000,000        
Note Receivable, Interest Rate, Stated Percentage           6.00%        
Interest Costs Capitalized                 $ 212,601 $ 753,977
Proceeds from Collection of Notes Receivable                 1,385,951 0
Payments to Acquire Notes Receivable                 0 175,000
Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Interest Income, Related Party             $ 0 $ 6,482 0 13,035
Proceeds from Collection of Notes Receivable   $ 342,567                
Financing Receivable, after Allowance for Credit Loss     $ 325,000              
Debt Instrument, Face Amount         $ 500,000          
Line of Credit Facility, Description         Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company          
Debt Instrument, Interest Rate, Stated Percentage         8.00%          
Payments to Acquire Notes Receivable     $ 175,000 $ 150,000            
Principal [Member] | Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable   325,000                
Accrued Interest [Member] | Joint Venture with CannAssist [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable   $ 17,567                
In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Business Combination, Consideration Transferred           $ 47,500,000        
Payments to Acquire Businesses, Gross           35,000,000        
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000        
Interest Income, Related Party             50,162 $ 75,616 110,727 $ 150,411
Interest Costs Capitalized $ 399,453                  
Proceeds from Collection of Notes Receivable             750,000   1,500,000  
Financing Receivable, after Allowance for Credit Loss             2,656,224   2,656,224  
Interest Receivable             0   0  
Option Agreement, Brake-Up Fee           $ 2,500,000        
Interest Rate, Default           15.00%        
Debt Instrument, Interest Rate, Stated Percentage           6.00%        
In Good Health [Member] | Principal [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable             688,869   697,082  
In Good Health [Member] | Accrued Interest [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable             $ 61,131   $ 52,918  
Option Agreement [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Business Combination, Consideration Transferred           $ 47,500,000        
Payments to Acquire Businesses, Gross           35,000,000        
Business Combination, Consideration Transferred, Liabilities Incurred           7,500,000        
Business Combination, Consideration Transferred, Other           $ 2,500,000        
Debt Instrument, Term           5 years        
Option Agreement [Member] | Restricted Stock [Member] | In Good Health [Member]                    
Joint Venture and Options Transaction (Details) [Line Items]                    
Equity Issued in Business Combination, Fair Value Disclosure           $ 5,000,000